Equity (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Equity [Line Items] |
|
| Schedule of Stock Warrant Activity |
Stock
warrant activity for the three months ended March 31, 2026 was as follows:
| | |
Number of
Warrants | | |
Weighted Average
Exercise Price | |
| Outstanding at January 1, 2026 | |
| 95,746 | | |
$ | 24.06 | |
| Repricing adjustment | |
| 1,722,556 | | |
$ | 0.33 | |
| Granted | |
| 13,063,728 | | |
$ | 0.51 | |
| Exercised | |
| (1,733,571 | ) | |
$ | (0.33 | ) |
| Outstanding at March 31, 2026 | |
| 13,148,459 | | |
$ | 0.64 | |
| Exercisable at March 31, 2026 | |
| 84,731 | | |
$ | 20.40 | |
|
| Schedule of Number of Pre-Funded Warrants Outstanding |
The
number of pre-funded warrants outstanding as of March 31, 2026 is as follows:
| Description | |
Number
Outstanding | | |
Weighted Average
Exercise Price | |
| Pre-funded warrants issued in December 2024 | |
| 150,000 | | |
$ | 0.01 | |
| Pre-funded warrants issued in February 2026 | |
| 5,882,353 | | |
$ | 0.0001 | |
| Outstanding at March 31, 2026 | |
| 6,032,353 | | |
$ | 0.0003 | |
|
| Schedule of Pre-Funded Warrant Activity |
A
summary of pre-funded warrant activity during the three months ended March 31, 2026 is as follows:
| | |
Number of
Pre-Funded
Warrants | | |
Weighted Average
Exercise Price | |
| Outstanding at January 1, 2026 | |
| 504,300 | | |
$ | 0.0030 | |
| Pre-funded warrants granted | |
| 5,882,353 | | |
$ | 0.0001 | |
| Pre-funded warrants exercised | |
| (354,300 | ) | |
$ | (0.0001 | ) |
| Outstanding at March 31, 2026 | |
| 6,032,353 | | |
$ | 0.0003 | |
|
| Options [Member] |
|
| Equity [Line Items] |
|
| Schedule of Common Stock Issuable Upon Exercise of Options Outstanding |
The
following table summarizes the shares of the Company’s common stock issuable upon exercise
of options outstanding at March 31, 2026:
| | Options Outstanding | | | Options Exercisable | | | | Range of
Exercise Price | | | Number
Outstanding at
March 31,
2026 | | | Weighted Average
Remaining
Contractual Life
(Years) | | | Weighted
Average
Exercise
Price | | | Number
Exercisable at
March 31,
2026 | | | Weighted
Average
Exercise
Price | | | $ | 2.93 – 31.20 | | | | 15,419 | | | | 2.57 | | | $ | 6.49 | | | | 15,419 | | | $ | 6.49 | | | $ | 48.75 – 123.00 | | | | 18,117 | | | | 0.98 | | | $ | 79.87 | | | | 18,117 | | | $ | 79.87 | | | $ | 154.50 – 228.00 | | | | 7,633 | | | | 3.75 | | | $ | 225.72 | | | | 7,633 | | | $ | 225.72 | | | $ | 2.93 – 228.00 | | | | 41,169 | | | | 2.09 | | | $ | 79.43 | | | | 41,169 | | | $ | 79.43 | |
|
| Warrants [Member] |
|
| Equity [Line Items] |
|
| Schedule of Common Stock Issuable Upon Exercise of Options Outstanding |
The
following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at March
31, 2026:
| Warrants Outstanding | | | Warrants Exercisable | | Range of
Exercise Price | | | Number
Outstanding at
March 31,
2026 | | | Weighted
Average
Remaining
Contractual Life
(Years) | | | Weighted
Average
Exercise Price | | | Number Exercisable at
March 31, 2026 | | | Weighted
Average
Exercise
Price | | | $ | 0.37 – 0.64 | | | | 13,132,713 | | | | 3.20 | | | $ | 0.51 | | | | 68,985 | | | $ | 0.37 | | | $ | 9.75 – 37.50 | | | | 6,593 | | | | 3.10 | | | $ | 14.26 | | | | 6,593 | | | $ | 14.26 | | | $ | 67.50 | | | | 889 | | | | 2.18 | | | $ | 67.50 | | | | 889 | | | $ | 67.50 | | | $ | 187.50 | | | | 8,264 | | | | 1.06 | | | $ | 187.50 | | | | 8,264 | | | $ | 187.50 | | | $ | 0.37 – 187.50 | | | | 13,148,459 | | | | 3.20 | | | $ | 0.64 | | | | 84,731 | | | $ | 20.40 | |
|